ABSTRACT: Collecting duct carcinoma (CDC), or Bellini duct carcinoma, is a rare and aggressive subtype of renal cell carcinoma, accounting for 0.2% - 1% of cases. It often presents at an advanced ...

Casdatifan (Cas) monotherapy in patients (pts) with previously treated clear cell renal cell carcinoma (ccRCC): Safety, efficacy and subgroup analysis across multiple doses from ARC-20, a phase 1 open ...

Association between baseline and changes in hemoglobin levels and treatment response and prognosis in metastatic renal cell carcinoma: A Mexican retrospective study.

Your kidney function test results are a measure of how well your kidneys are working to filter your blood and remove excess water and waste from the body. For example, the estimated glomerular ...

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...

Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...

Dr. Xiaofan Lu presented the Abstract 442: Racial disparities in renal cell carcinoma histology and outcomes: Insights from the French Kidney Cancer Research Network (UroCCR-191). Racial disparities ...

Kidney cancer-- also called renal cell cancer-- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in ...

An artificial intelligence platform may help identify BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) and steer alternative treatment.